BofA Merrill Lynch, Barclays and Leerink Swann were joint bookrunners
By Devika Patel
Knoxville, Tenn., April 16 - Omthera Pharmaceuticals, Inc. said it completed a $64 million initial public offering of stock.
The company sold 8 million common shares at $8.00 per share.
BofA Merrill Lynch, Barclays and Leerink Swann were the joint bookrunning managers.
The specialty pharmaceutical company is based in Princeton, N.J.
| Issuer: | Omthera Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $64 million
|
| Shares: | 8 million
|
| Price: | $8.00
|
| Warrants: | No
|
| Bookrunners: | BofA Merrill Lynch, Barclays and Leerink Swann
|
| Co-managers: | Stifel, Nicolaus & Co. Inc. and Piper Jaffray & Co.
|
| Settlement date: | April 16
|
| Stock symbol: | Nasdaq: OMTH
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
